Dorsey Wright & Associates’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,492
Closed -$24K 322
2020
Q3
$24K Sell
1,492
-498
-25% -$8.16K ﹤0.01% 151
2020
Q2
$29K Hold
1,990
0.01% 158
2020
Q1
$14K Sell
1,990
-103
-5% -$809 0.01% 116
2019
Q4
$12K Buy
+2,093
New +$10.8K ﹤0.01% 190

Other funds holding CGEN

Dorsey Wright & Associates's CGEN Position: Q4 2020 in Review

Dorsey Wright & Associates sold out of Compugen (CGEN) in Q4 2020, closing a stake of 1,492 shares — an estimated $24K sold.

Dorsey Wright & Associates first reported a position in CGEN in Q4 2019 and held it in 4 quarters. The position peaked at $29K in Q2 2020. 101 funds tracked by Wall St. Rank hold CGEN as of Q4 2020.

  • Dorsey Wright & Associates reported no remaining Compugen position as of Q4 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,492 Compugen shares in Q4 2020, an estimated $24K.
  • Dorsey Wright & Associates first reported a position in Compugen in Q4 2019 and held it in 4 quarters.
  • Dorsey Wright & Associates's Compugen position peaked at $29K in Q2 2020.
  • 101 funds tracked by Wall St. Rank held Compugen as of Q4 2020.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.